These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25114627)

  • 1. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
    Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
    Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment.
    Iglesias E; Torrente-Segarra V; Bou R; Ricart S; González MI; Sánchez J; Calzada J; Antón J
    Rheumatol Int; 2014 Aug; 34(8):1053-7. PubMed ID: 24162563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
    Glerup M; Herlin T; Twilt M
    Clin Rheumatol; 2017 Mar; 36(3):671-676. PubMed ID: 28097448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for comorbid autoimmune disease should be considered in children with ANA positive juvenile idiopathic arthritis - results from the south-Swedish juvenile idiopathic arthritis cohort.
    Dahlberg A; Tydén H; Jöud AS; Kahn F; Berthold E
    Pediatr Rheumatol Online J; 2024 Oct; 22(1):92. PubMed ID: 39425228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Huber AM; Watanabe Duffy K; Boire G; Shiff N; Berard RA; Levy DM; Stringer E; Scuccimarri R; Morishita K; Johnson N; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Bruns A; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SM; Bolaria R; Gross K; Feldman B; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RS; Duffy CM; Tucker LB;
    Ann Rheum Dis; 2016 Jun; 75(6):1092-8. PubMed ID: 25985972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
    Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
    Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of antinuclear antibody tests in children.
    McGhee JL; Kickingbird LM; Jarvis JN
    BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis.
    Serra CR; Rodrigues SH; Silva NP; Sztajnbok FR; Andrade LE
    Clin Exp Rheumatol; 1999; 17(3):375-80. PubMed ID: 10410276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveitis Associated with Juvenile Idiopathic Arthritis, our Observations.
    Cosickic A; Halilbasic M; Selimovic A; Avdagic H
    Med Arch; 2017 Feb; 71(1):52-55. PubMed ID: 28428675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany.
    Heiligenhaus A; Klotsche J; Niewerth M; Horneff G; Ganser G; Haas JP; Minden K
    Arthritis Res Ther; 2020 Apr; 22(1):81. PubMed ID: 32293540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).
    Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J;
    Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic onset juvenile idiopathic arthritis: a single center experience.
    Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
    Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
    Fitzpatrick L; Broadaway KA; Ponder L; Angeles-Han ST; Jenkins K; Rouster-Stevens K; Pelajo CF; Conneely K; Epstein MP; Lopez-Benitez J; Vogler LB; Prahalad S;
    J Rheumatol; 2016 Apr; 43(4):799-803. PubMed ID: 26879356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.
    Reyhan I; Zhukov OS; Lagier RJ; Bridgforth RF; Williams GJ; Popov JM; Naides SJ; Reiff A
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):14. PubMed ID: 33593401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile Idiopathic Arthritis.
    Sudhakar M; Kumar S
    Indian J Pediatr; 2024 Sep; 91(9):949-958. PubMed ID: 38163829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.
    Lainka E; Baehr M; Raszka B; Haas JP; Hügle B; Fischer N; Foell D; Hinze C; Weissbarth-Riedel E; Kallinich T; Horneff G; Windschall D; Lilienthal E; Niehues T; Neudorf U; Berendes R; Küster RM; Oommen PT; Rietschel C; Lutz T; Weller-Heinemann F; Tenbrock K; Heubner GL; Klotsche J; Wittkowski H
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):38. PubMed ID: 33752669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibody-positive cohort constitutes homogeneous entity in juvenile idiopathic arthritis.
    Ma X; Xin L; Sun J; Liu Z
    Mod Rheumatol; 2016; 26(1):75-9. PubMed ID: 26025435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.